logo

Tehran Times Covers MAHAK’s Childhood Cancer Awareness Month Press Conference

  • 30 September 26
  • 18 revirew
  • 0 comment

Tehran Times has published a report on MAHAK’s recent press conference held during Childhood Cancer Awareness Month, highlighting the organization’s international cooperation and its role in advancing childhood cancer care in Iran.

The press conference, titled “From Transplantation to Innovative Treatments: MAHAK’s Vision for the Future of Treatment and Support for Children with Cancer,” was held on September 22, 2026, at MAHAK’s Arkan Hall. The event brought together MAHAK managers and specialists from the fields of treatment, transplantation, laboratory services, research, public relations, and international affairs, as well as representatives of national and international media.

In its coverage, Tehran Times focused particularly on remarks by Dr. Arasb Ahmadian, CEO of MAHAK, regarding the organization’s international cooperation with major global cancer networks and professional bodies. The report referred to MAHAK’s engagement with organizations including the Union for International Cancer Control (UICC), Childhood Cancer International (CCI), and the International Society of Paediatric Oncology (SIOP).

According to the report, these international partnerships provide opportunities for the exchange of knowledge and experience, capacity building, scientific cooperation, and professional collaboration in the field of childhood cancer treatment and support. Tehran Times also highlighted MAHAK’s activities across its three main areas of charity, hospital services, and research.

The publication of the report reflects the media attention generated by MAHAK’s Childhood Cancer Awareness Month press conference and contributes to broader public awareness of the organization’s treatment, research, and international activities.

The full Tehran Times report, titled “MAHAK strengthens international cooperation in childhood cancer care,” is available on the newspaper’s website.

comments

Share your comments *Your email address will be safe with us.